期刊文献+

IL-4和IL-13在甲状腺乳头状癌中的表达及其与临床病理特征和预后的关系 被引量:3

Expression of IL-4 and IL-13 in thyroid papillary carcinoma and their relationship with clinicopathological parameters and prognosis
下载PDF
导出
摘要 目的:探讨甲状腺乳头状癌(papillary thyroid carcinoma,PTC)肿瘤组织中IL-4和IL-13的表达情况及其与临床病理特征、患者术后复发(包括转移)的关系。方法:收集经病理证实的PTC及癌旁组织标本185例,另取正常甲状腺组织20例作为对照组。采用免疫组织化学法检测组织中IL-4和IL-13蛋白表达情况。结果:癌组织中IL-4蛋白的阳性表达率为95.68%,显著高于癌旁组织37.84%和正常组织5.00%(P<0.05)。癌组织中IL-13蛋白的阳性表达率为90.81%,显著高于癌旁组织41.08%和正常组织0.00%(P<0.05)。IL-4和IL-13表达情况与肿瘤最大直径、浸润深度、分化程度、TNM分期等临床特征均有明显相关性(P<0.05)。IL-4高表达组术后复发率显著高于IL-4低表达组,差异有统计学意义(χ~2=5.491,P=0.019)。IL-13高表达组术后复发率显著高于IL-13低表达组,差异有统计学意义(χ~2=4.345,P=0.037)。COX回归分析结果显示:IL-4高表达和IL-13高表达是影响PCT患者术后复发的独立危险因素(P<0.05)。结论:IL-4和IL-13在PTC肿瘤组织中表达上调,与肿瘤最大直径、浸润深度、分化程度和TNM分期有关,IL-4和IL-13在肿瘤组织中的高表达是术后复发(包括转移)的独立危险因素。 Objective: To investigate the expression of IL-4 and IL-13 in papillary thyroid carcinoma(PTC) and its relationship with clinicopathological features and postoperative recurrence(including metastasis). Methods: A total of 185 cases of pathologically confirmed papillary thyroid carcinoma and adjacent tissues were collected. Another 20 cases of normal thyroid tissue as a control group. Immunohistochemistry was used to detect the expression of IL-4 and IL-13 in the tissues. Results: The positive rate of IL-4 protein in cancer tissues was 95.68%, which was significantly higher than that in adjacent tissues 37.84% and normal tissues 5.00%(P〈0.05). The positive rate of IL-13 protein in cancer tissues was 90.81%, which was significantly higher than that in adjacent tissues 41.08% and normal tissues 0.00%(P〈0.05). The expression of IL-4 and IL-13 had significant relationship with clinical features such as tumor size, depth of invasion, differentiation and TNM staging(P0.05). The recurrence rate of high IL-4 expression group was significantly higher than that of low IL-4 expression group(χ^2=5.491, P=0.019). The recurrence rate of IL-13 high expression group was significantly higher than that of IL-13 low expression group, the difference was statistically significant(χ^2=4.345, P=0.037). COX regression analysis showed that high expression of IL-4 and high expression of IL-13 were independent risk factors for postoperative recurrence in patients with PCT(P0.05). Conclusion: IL-4 and IL-13 in PTC tumor tissue are upregulated, and are related to tumor size, depth of invasion, differentiation and TNM staging, and the high expression of IL-4 and IL-13 in tumor tissue is an independent risk factor for postoperative recurrence(including metastasis).
作者 刘瑞 罗前程 朱鸿玲 尤文 沈佩玲 王星 李湘麒 顾明君 LIU Rui;LUO Qiancheng;ZHU Hongling;YOU Wen;SHEN Peiling;WANG Xing;LI Xiangqi;GU Mingjun(Department of Endocrinology;Department of Emergency Medicine, Public Hospital of Shanghai Pudong District, Shanghai 200135, China)
出处 《临床与病理杂志》 2018年第3期490-497,共8页 Journal of Clinical and Pathological Research
基金 上海市卫生和计划生育委员会科研课题(201440050)~~
关键词 甲状腺乳头状癌 白细胞介素-4 白细胞介素-13 临床病理特征 预后 thyroid papillary carcinoma interleukin-4 interleukin-13 clinicopathological features prognosis
  • 相关文献

参考文献8

二级参考文献70

  • 1谢宇锋,盛伟华,缪竞诚,杨吉成.人IL-17F对裸鼠人肝癌移植瘤生长的影响[J].生物工程学报,2006,22(5):772-778. 被引量:3
  • 2Su LP, Zhang JP, Xu HB,et al. Differential expression of CXCR4 is associated with the metastatic potential of human non-small lung cancer cells[J]. Clin Cancer Res, 2005, 11 (10) : 8273 -8280.
  • 3Kondo T, Ezzat S, Asa SL, et al. Pathogenetic mechanisms in thyroid follicular-cell meoplasia [ J ]. Nat Rev Cancer, 2006, 6 (4) :292 - 306.
  • 4Formentini A, Prokopchuk O, Strater J, et al. Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases[J]. Int J Colorectal Dis, 2009, 24( 1 ) : 57 -67.
  • 5Marotti B, Rocco A, De Colibus P, et al. Interleukin-13 mucosal production in helicobacter pylori-related gastric diseases [ J ]. Dig Liver Dis. 2008, 40(4) :240 -247.
  • 6Zhao Z, Wei Q, Zhao Y, et al. Genetic copy number alterations and IL-13 expression differenees in papillary thyroid cancers and benign nodules[J]. Endocrine, 2009, 36(1):155 - 160.
  • 7Tamamura H, Hori A, Kanzaki N, et al. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer[ J ]. FEBS Lett, 2003, 550 ( 1 - 3 ) :79 - 83.
  • 8Castellone MD, Guarino V, Falco VD, et al. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human palillary thyroid carcinomas[ J].Oncogene, 2004, 23(35):5958-5967.
  • 9Wagner PL, Moo TA, Arora N, et al. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma [J]. AnnSurgOnco, 2008, 15(10) :2833 -2841.
  • 10Jung KW, Won Y J, Kong H J, et al. Cancer statistics in Korea: in- cidence, mortality, survival and prevalence in 2012 [J]. Cancer Res Treat, 2015, 47(2):127-141.

共引文献312

同被引文献23

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部